We are proud to announce that QIAGEN Clinical Insight (QCI®), QIAGEN’s clinical decision support platform has achieved a milestone: over 1 million patient test cases analyzed and interpreted.
Supporting more than 1,000 clinical laboratories and physicians worldwide, the cloud-based QCI platform provides all of the capabilities required to transform complex data from next-generation sequencing (NGS) into actionable insights. The two platform components—QCI Analyze and QCI Interpret—simplify and streamline variant analysis and interpretation, yielding standardized, evidence-based reports with actionable information.
“Surpassing 1 million patient test cases is a strong validation for QCI. More than 1,000 customers worldwide have uploaded and processed patient tests, ranging from targeted panels to whole exome or genome results across multiple indications, germline to somatic cancer, to gain actionable insights from the QIAGEN Knowledge Base.”
Dr. Jonathan Sheldon, Senior Vice President and Head of QIAGEN’s Bioinformatics Business Area
“This knowledge base is the industry’s most expansive collection of expert-curated biological and clinical findings built from over 20 years of manual data and literature curation, enabling deep clinical insights across a broad range of disease indications,” says Sheldon. “While handling 1 million patient cases is a monumental milestone, this is just the beginning. We are now supporting large-scale programs for precision medicine like Genomics England and the National Cancer Center Japan and are seeing the realization of our goal of using bioinformatics to make improvements in life possible.”